ALZ Survivor Sally Uses The Bredesen ProtocolTM
Sally is an ALZ survivor who uses The Bredesen ProtocolTM. Consequently, she has her life back! Due to staying on her customized program, Sally continues to be an ALZ survivor. Sally isn’t the only one to reverse her cognitive decline. There are hundreds of people on the Protocol who have done the same and now have their lives back. These ALZ survivors continue to follow their individualized programs. However, those who fall off their programs notice a decline in their thought processes.
These are people who were diagnosed with Alzheimer’s and in some cases told to begin closing down their businesses. Yet, once they sought a Bredesen trained physician or health care practitioner, their decline halted and their cognition began to improve. Furthermore, these patients were not only able to return to work, but in some cases expand their businesses, travel the world, or learn a new language!
The Proper Evaluation & Testing Developed by Dr. Dale E. Bredesen
After 30 years of research, Dr. Dale E. Bredesen, neurologist and neuroscientist, developed The Bredesen ProtocolTM. Chiefly, his Protocol works because the physician isn’t treating the patient blindly. The proper evaluation and testing, called a CognoscopyTM, includes these simple tests:
– blood tests (chemical, hormonal, metabolic and toxicity tests)
– genetic tests
– a simple online cognitive assessment
– a brain MRI (if needed)
From the CognoscopyTM, a computerized program develops an assessment and personalized program for the patient. Then, whatever threats are revealed through testing, they are addressed. The Protocol also focuses largely on diet, fasting, exercise, sleep, stress reduction, and other lifestyle factors.
Update 4/24/19: Sally continues to do well and is now four years into The Bredesen ProtocolTM. In addition, Sally scored a perfect 30 out of 30 on the MoCA (Montreal Cognitive Assessment) Test for Dementia. Go Sally! More about Sally and other ALZ survivors using The Bredesen ProtocolTM.
Survivors Exist in Growing Numbers …
What is The Bredesen ProtocolTM?
The protective response causes APP (Amyloid Precursor Protein, the long molecule that protrudes from neurons) to be cut into four fragments, including amyloid-beta, that downsize the neural network and eventually destroy synapses and neurons. When the APP molecule is cut into those four pieces, it is not cut into the two pieces that nourish and maintain synapses.
Alzheimer's disease is a state of the brain in which there is an imbalance between the reorganization of synapses that have outlived their usefulness (and which the brain can stand to lose - healthy destruction) and the maintenance or creation of existing and new synapses (which the brain needs to sustain old memories and form new ones, as well as perform other cognitive functions). That imbalance comes from too many of the synapse- and neuron-destroying quartet of molecules snipped from APP and too few of the synapse- and neuron-sustaining duo of molecules snipped from APP.